EP Patent

EP0572932B1 — Method and implant device for long term delivery of drugs

Assigned to CR Bard Inc · Expires 2000-09-13 · 26y expired

What this patent protects

Patent listed against Gemzar.

Drugs covered by this patent

Gemzar (Gemcitabine Hydrochloride) · Accord Hlthcare

Patent Metadata

Patent number: EP0572932B1
Jurisdiction: EP
Classification: —
Expires: 2000-09-13
Drug substance claim: No
Drug product claim: No
Assignee: CR Bard Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.